Surgery and Wegovy: what you need to know before going under anaesthetic

Step 1, Tell your surgical team as early as possible

This is the single most important action. As soon as surgery is scheduled, make sure your surgeon, anaesthetist, and anyone managing your pre-operative assessment knows you are taking semaglutide (Wegovy). The interaction between GLP-1 medicines and anaesthesia is well-recognised in UK clinical practice, and anaesthetists are increasingly familiar with it, but only if they know in advance.

The reason the disclosure matters so much comes down to gastric emptying. Wegovy reduces the speed at which food and liquid leave the stomach. Even if you have fasted according to standard pre-operative instructions, there is a real possibility that stomach contents remain. Under sedation or general anaesthetic, the normal reflexes that prevent regurgitation are suppressed, and aspirating stomach contents into the lungs is a potentially life-threatening event. Whether to continue or stop Wegovy before surgery is therefore a clinical question, not a personal preference.

NHS England guidance on weight-management injections explicitly states that patients should inform their healthcare team, including the anaesthetist, before any surgical procedure. That guidance applies to both elective and planned urgent procedures.

Step 2, Understand what your teams are weighing up

A question our prescribers hear most weeks is whether stopping Wegovy briefly will undo months of progress. It is a fair concern, and the honest answer is that a short pause is unlikely to reverse meaningful weight loss, but the timing and duration of any pause must be tailored to the individual.

There is currently no single fixed UK standard specifying exactly how many days before surgery Wegovy should be stopped. Guidance is evolving. Some anaesthesia societies have suggested pausing weekly GLP-1 injections for one full dosing cycle before elective procedures with general anaesthetic (that would be roughly a week for a once-weekly injection) but the right interval depends on the dose, whether you have any symptoms of delayed gastric emptying, the urgency of the procedure, and local anaesthetic team protocols.

For emergency surgery, the team will manage the risk differently, typically by treating the patient as having a full stomach and taking precautions at induction. Guidance on stopping Wegovy ahead of surgery covers this in more detail, but the operative word throughout is that your clinical team leads that decision.

Your prescriber at nume can also advise on the medical management side, including any documentation your surgical team may want about your current dose and last injection date.

Step 3, Plan your restart carefully after surgery

Recovery from surgery involves its own demands on the body: reduced appetite, nausea from anaesthetic, potential fluid and nutritional challenges, and sometimes medication changes. Reintroducing Wegovy into that picture is not automatically straightforward.

Restarting at the same dose you paused at may be appropriate for some people, but others may need to retitrate from a lower dose, particularly if there has been significant gastrointestinal upset post-operatively or a longer pause than anticipated. This is a conversation for your prescriber and surgical team to have together, ideally before you are discharged.

It is also worth thinking about other things that interact with how Wegovy behaves during recovery, including alcohol, which some surgical teams advise avoiding during healing. Keep your prescriber informed of how recovery is going.

For anyone considering Wegovy for weight management in the first instance, a full overview of how Wegovy works, what the evidence shows, and what the licensed eligibility criteria are is a reasonable starting point. NHS England's guidance on weight-management injections also addresses surgical considerations and is the clinical reference our prescribers follow.

A note on uncertainty and who to consult

The evidence base around GLP-1 medicines and anaesthesia is still developing. Guidance from anaesthetic societies, NHS England, and individual surgical departments does not always align precisely, and recommendations may be updated as more data emerge. That uncertainty is not a reason for alarm, but it does mean that generic advice from any single source, including this page, should be verified with the clinical team managing your specific procedure.

If you are already on Wegovy through a private prescription route and have received a surgical referral, contact your prescriber promptly. At nume, our aftercare team is available seven days a week and can coordinate the clinical documentation your surgical team may need. If you are still weighing up whether Wegovy is right for you and have a history of abdominal surgery or known gastric motility problems, that context belongs in your initial consultation. Our clinical team reviews every case individually before any prescription is issued.

Separately, Wegovy is not recommended during pregnancy or breastfeeding, or for anyone actively trying to conceive. If surgery is planned as part of fertility treatment, or if pregnancy is a possibility, raise that with your prescriber as a distinct point. The guidance on Wegovy and pregnancy covers what is known.